109 related articles for article (PubMed ID: 6418891)
1. Importance of unbound phenytoin serum levels in head trauma patients.
Bauer LA; Edwards WA; Dellinger EP; Raisys VA; Brennan C
J Trauma; 1983 Dec; 23(12):1058-60. PubMed ID: 6418891
[TBL] [Abstract][Full Text] [Related]
2. Revised Winter-Tozer equation for normalized phenytoin concentrations in trauma and elderly patients with hypoalbuminemia.
Anderson GD; Pak C; Doane KW; Griffy KG; Temkin NR; Wilensky AJ; Winn HR
Ann Pharmacother; 1997 Mar; 31(3):279-84. PubMed ID: 9066931
[TBL] [Abstract][Full Text] [Related]
3. Effect of acute phase response on phenytoin metabolism in neurotrauma patients.
McKindley DS; Boucher BA; Hess MM; Rodman JH; Feler C; Fabian TC
J Clin Pharmacol; 1997 Feb; 37(2):129-39. PubMed ID: 9055139
[TBL] [Abstract][Full Text] [Related]
4. Phenytoin protein binding in pediatric patients with acute traumatic injury.
Griebel ML; Kearns GL; Fiser DH; Woody RC; Turley CP
Crit Care Med; 1990 Apr; 18(4):385-91. PubMed ID: 1969339
[TBL] [Abstract][Full Text] [Related]
5. Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate--the predictive value of plasma albumin concentration.
Johnson GJ; Kilpatrick CJ; Bury RW; Fullinfaw RO; Moulds RF
Br J Clin Pharmacol; 1989 Jun; 27(6):843-9. PubMed ID: 2503019
[TBL] [Abstract][Full Text] [Related]
6. Early post-traumatic epilepsy prophylaxis.
Young B; Rapp RP; Perrier D; Kostenbauder H; Hackman J; Blacker HM
Surg Neurol; 1975 Sep; 4(3):339-42. PubMed ID: 809855
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of unbound phenytoin in the management of epilepsy.
Kilpatrick CJ; Wanwimolruk S; Wing LM
Br J Clin Pharmacol; 1984 May; 17(5):539-46. PubMed ID: 6733002
[TBL] [Abstract][Full Text] [Related]
8. Phenytoin protein binding and dosage requirements during acute and convalescent phases following brain injury.
Markowsky SJ; Skaar DJ; Christie JM; Eyer SD; Ehresman DJ
Ann Pharmacother; 1996 May; 30(5):443-8. PubMed ID: 8740320
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic phenytoin in severe head injuries.
Wohns RN; Wyler AR
J Neurosurg; 1979 Oct; 51(4):507-9. PubMed ID: 113510
[TBL] [Abstract][Full Text] [Related]
10. Variability of phenytoin protein binding in epileptic patients.
DeMonaco HJ; Lawless LM
Arch Neurol; 1983 Aug; 40(8):481-3. PubMed ID: 6347141
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of therapeutic phenytoin plasma levels via intramuscular administration.
Perrier D; Rapp R; Young B; Kostenbauder H; Cady W; Pancorbo S; Hackman J
Ann Intern Med; 1976 Sep; 85(3):318-21. PubMed ID: 822764
[TBL] [Abstract][Full Text] [Related]
12. The quantitative effect of serum albumin, serum urea, and valproic acid on unbound phenytoin concentrations in children.
ter Heine R; van Maarseveen EM; van der Westerlaken MM; Braun KP; Koudijs SM; Berg MJ; Malingré MM
J Child Neurol; 2014 Jun; 29(6):803-10. PubMed ID: 23670246
[TBL] [Abstract][Full Text] [Related]
13. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
Kerrick JM; Wolff DL; Graves NM
Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
[TBL] [Abstract][Full Text] [Related]
14. Unbound plasma phenytoin concentrations measured using enzyme immunoassay technique on the cobas MIRA analyser--in vivo effect of valproic acid.
Sallustio BC; Morris RG
Ther Drug Monit; 1992 Feb; 14(1):9-13. PubMed ID: 1546396
[TBL] [Abstract][Full Text] [Related]
15. Ultrafiltration compared with equilibrium dialysis in the determination of unbound phenytoin in plasma.
Koike Y; Magnusson A; Steiner E; Rane A; Sjöqvist F
Ther Drug Monit; 1985; 7(4):461-5. PubMed ID: 3909538
[TBL] [Abstract][Full Text] [Related]
16. Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.
Barth N; Alván G; Borgå O; Sjöqvist F
Clin Pharmacokinet; 1976; 1(6):444-52. PubMed ID: 1024769
[TBL] [Abstract][Full Text] [Related]
17. Predicting Unbound Phenytoin Concentrations: Effects of Albumin Concentration and Kidney Dysfunction.
Montgomery MC; Chou JW; McPharlin TO; Baird GS; Anderson GD
Pharmacotherapy; 2019 Jul; 39(7):756-766. PubMed ID: 31067355
[TBL] [Abstract][Full Text] [Related]
18. A case study of two methods of administering phenytoin enterally and the subsequent serum phenytoin levels in head-injured patients.
Bader MK
J Neurosci Nurs; 1993 Feb; 25(1):57-8. PubMed ID: 8445276
[No Abstract] [Full Text] [Related]
19. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures.
Temkin NR; Dikmen SS; Wilensky AJ; Keihm J; Chabal S; Winn HR
N Engl J Med; 1990 Aug; 323(8):497-502. PubMed ID: 2115976
[TBL] [Abstract][Full Text] [Related]
20. Predicting unbound phenytoin concentrations in the critically ill neurosurgical patient.
Mlynarek ME; Peterson EL; Zarowitz BJ
Ann Pharmacother; 1996 Mar; 30(3):219-23. PubMed ID: 8833553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
